PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment

Cardiovascular disease (CVD) is the leading cause of death in patients with diabetes, and tight glycemic control fails to reduce the risk of developing CVD. Thiazolidinediones (TZDs), a class of peroxisome proliferator–activated receptor γ (PPARγ) agonists, are potent insulin sensitizers with antiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Longhua, Fan, Lihong, Chan, Michelle, Kraakman, Michael J., Yang, Jing, Fan, Yong, Aaron, Nicole, Wan, Qianfen, Carrillo-Sepulveda, Maria Alicia, Tall, Alan R., Tabas, Ira, Accili, Domenico, Qiang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372079/
https://www.ncbi.nlm.nih.gov/pubmed/32409492
http://dx.doi.org/10.2337/db20-0217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372079/
https://www.ncbi.nlm.nih.gov/pubmed/32409492
http://dx.doi.org/10.2337/db20-0217

Ejemplares similares